Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 160

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Increased ALK Gene Copy Number and Amplification are Frequent in Non-small Cell Lung Cancer

Open access
Salido, Marta, Pijuan, Lara, Martínez-Avilés, Luz, Galván, Ana B., Cañadas, Israel, Rovira, Ana, Zanui, Montserrat, Martínez, Alejandro, Longarón, Raquel, Sole, Francisco, Serrano, Sergio, Bellosillo, Beatriz, Wynes, Murry W., Albanell, Joan, Hirsch, Fred R., Arriola, Edurne · 2011 · Journal of Thoracic Oncology

Abstract

Introduction: Translocation of the anaplastic lymphoma kinase (ALK) gene is involved in the tumorigenesis of a subset of non-small cell lung carcinomas (NSCLCs) and identifies patients sensitive to ALK inhibitors. ALK copy number changes and amplification, which plays an oncogenic role in tumors such as neuroblastoma, are poorly characterized in NSCLC. We aimed to study the prevalence of ALK copy number changes and their correlation to ALK protein expression, epidermal growth factor receptor (EGFR) status, and clinicopathological data in patients with NSCLC. Methods: ALK status was evaluated by fluorescence in situ hybridization (FISH). Specimens with ALK translocation were studied for echinoderm microtubule-associated protein-like 4 (EML4), KIF5B, and TFG status. ALK expression was assessed by immunohistochemistry. EGFR gene and protein status were evaluated in adenocarcinomas. Survival analysis was performed. Results: One hundred seven NSCLC cases were evaluated. There were two cases of EML4-ALK translocation and one with an atypical translocation of ALK. Both cases of EML4-ALK translocation had ALK protein expression, whereas in the rest, ALK was undetected. Eleven cases (10%) exhibited ALK amplification and 68 (63%) copy number gains. There was an association between ALK amplification and EGFR FISH positivity (p < 0.0001) but not with prognosis. In conclusion, EML4-ALK translocation is a rare event in NSCLC. Conclusion: The study reveals a significant frequency of ALK amplification and its association with EGFR FISH positivity in lung adenocarcinomas. Based on these findings, a potential role of ALK amplification in the response to ALK inhibitors alone or combined with EGFR inhibitors in NSCLC merits further studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/jto.0b013e3181fb7cd6

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 160

Metadata

Authors
Salido, M., Pijuan, L., Martínez-Avilés, L., Galván, A. B., Cañadas, I., Rovira, A., Zanui, M., Martínez, A., Longarón, R., Sole, F., Serrano, S., Bellosillo, B., Wynes, M. W., Albanell, J., Hirsch, F. R., & Arriola, E.
Venue
Journal of Thoracic Oncology
Publisher
Elsevier BV
Published
2011-01
Volume
6
Issue
1
Pages
21-27
ISSN
1556-0864 (ISSN-L)
OpenAlex
W2134820929
Cited by
160
References
6
FWCI
13.04
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increased ALK Gene Copy Number and Amplification are Frequent in Non-small Cell Lung Cancer. https://app.cochat.ai/papers/10.1097/jto.0b013e3181fb7cd6
The paper
Salido, M., Pijuan, L., Martínez-Avilés, L., Galván, A. B., Cañadas, I., Rovira, A., Zanui, M., Martínez, A., Longarón, R., Sole, F., Serrano, S., Bellosillo, B., Wynes, M. W., Albanell, J., Hirsch, F. R., & Arriola, E. (2011). Increased ALK Gene Copy Number and Amplification are Frequent in Non-small Cell Lung Cancer. Journal of Thoracic Oncology. https://doi.org/10.1097/jto.0b013e3181fb7cd6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.